Long-Term Treatment With rhIGF-1 in GHIS
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Ipsen
Related studies linked through entity extraction aliases.
Lanreotide as Treatment of Polycystic Livers
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)
- Status
- WITHDRAWN
- Phase
- PHASE2
Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE3
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
- Status
- COMPLETED
- Phase
- PHASE4
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
- Status
- COMPLETED
- Phase
- N/A
A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders
- Status
- COMPLETED
- Phase
- N/A
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
- Status
- TERMINATED
- Phase
- PHASE2
Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
- Status
- COMPLETED
- Phase
- PHASE3
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)
- Status
- TERMINATED
- Phase
- PHASE2
Effectiveness of Botulinum Toxin Injection in the Tennis Elbow Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours
- Status
- COMPLETED
- Phase
- PHASE3